These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6237906

  • 1. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
    Machka K.
    Eur J Clin Microbiol; 1984 Aug; 3(4):374. PubMed ID: 6237906
    [No Abstract] [Full Text] [Related]

  • 2. Activity of ciprofloxacin against genital tract pathogens.
    Hart CA, How SJ, Hobson D.
    Br J Vener Dis; 1984 Oct; 60(5):316-8. PubMed ID: 6435814
    [Abstract] [Full Text] [Related]

  • 3. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    Diez-Enciso M, Mas-Jimenez G, Velasco-Cerrudo A, Gutierrez-Altes A.
    Eur J Clin Microbiol; 1984 Aug; 3(4):367. PubMed ID: 6237905
    [No Abstract] [Full Text] [Related]

  • 5. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD, DeYoung DR, Roberts GD.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of ciprofloxacin against group JK corynebacteria.
    Machka K, Balg H.
    Eur J Clin Microbiol; 1984 Aug; 3(4):375. PubMed ID: 6237907
    [No Abstract] [Full Text] [Related]

  • 8. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L, Saunders J, Traynor R, Koornhof HJ.
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [Abstract] [Full Text] [Related]

  • 9. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 10. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL, Mumtaz G, Gabriel FG, Oriel JD.
    Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
    Hoogkamp-Korstanje JA.
    Eur J Clin Microbiol; 1984 Aug; 3(4):333-8. PubMed ID: 6237901
    [Abstract] [Full Text] [Related]

  • 13. Activities of newer quinolones against Legionella group organisms.
    Greenwood D, Laverick A.
    Lancet; 1983 Jul 30; 2(8344):279-80. PubMed ID: 6135099
    [No Abstract] [Full Text] [Related]

  • 14. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1984 May 30; 25(5):633-7. PubMed ID: 6233935
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Wise R, Andrews JM, Edwards LJ.
    Antimicrob Agents Chemother; 1983 Apr 30; 23(4):559-64. PubMed ID: 6222695
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD, Saunders J, Fehler G, Ballard RC, Koornhof HJ.
    Antimicrob Agents Chemother; 1986 Dec 30; 30(6):948-50. PubMed ID: 3101590
    [Abstract] [Full Text] [Related]

  • 17. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr 30; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
    Meier-Ewert H, Weil G, Millott G.
    Eur J Clin Microbiol; 1984 Aug 30; 3(4):372. PubMed ID: 6593220
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW, Muytjens HL.
    Antimicrob Agents Chemother; 1984 Jan 30; 25(1):123-4. PubMed ID: 6230988
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1984 Mar 30; 25(3):319-26. PubMed ID: 6232895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.